Your browser doesn't support javascript.
loading
Sepsis and the Obesity Paradox: Size Matters in More Than One Way.
Jagan, Nikhil; Morrow, Lee E; Walters, Ryan W; Plambeck, Robert W; Wallen, Tanner J; Patel, Tej M; Malesker, Mark A.
Afiliação
  • Jagan N; Division of Pulmonary and Critical Care, Creighton University School of Medicine, Omaha, NE.
  • Morrow LE; Division of Pulmonary and Critical Care, Creighton University School of Medicine, Omaha, NE.
  • Walters RW; Division of Clinical Research and Evaluative Sciences, Creighton University School of Medicine, Omaha, NE.
  • Plambeck RW; Division of Pulmonary and Critical Care, Creighton University School of Medicine, Omaha, NE.
  • Wallen TJ; Department of Internal Medicine, Creighton University School of Medicine, Omaha, NE.
  • Patel TM; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO.
  • Malesker MA; Division of Pulmonary and Critical Care, Creighton University School of Medicine, Omaha, NE.
Crit Care Med ; 48(9): e776-e782, 2020 09.
Article em En | MEDLINE | ID: mdl-32590388
ABSTRACT

OBJECTIVES:

Multiple studies have demonstrated an obesity paradox such that obese ICU patients have lower mortality and better outcomes. We conducted this study to determine if the mortality benefit conferred by obesity is affected by baseline serum lactate and mean arterial pressure.

DESIGN:

Retrospective analysis of prospectively collected clinical data.

SETTING:

Five community-based and one academic medical center in the Omaha, NE. PATIENTS 7,967 adults hospitalized with sepsis.

INTERVENTIONS:

None. MEASUREMENTS AND MAIN

RESULTS:

Patients were categorized by body mass index as underweight, normal weight, overweight, or obese. Multivariable logistic regression models were used to estimate the odds of in-hospital death by body mass index category; two-way interactions between body mass index and each covariate were also evaluated. Subgroup and sensitivity analyses were conducted using an ICU cohort and Acute Physiology and Chronic Health Evaluation III scores, respectively. The overall unadjusted mortality rate was 12.1% and was consistently lower in higher body mass index categories (all comparisons, p < 0.007). The adjusted mortality benefit observed in patients with higher body mass index was smaller in patients with higher lactate levels with no mortality benefit in higher body mass index categories observed at lactate greater than 5 mmol/L. By contrast, the association between lower MAP and higher mortality was constant across body mass index categories. Similar results were observed in the ICU cohort. Finally, the obesity paradox was not observed after including Acute Physiology and Chronic Health Evaluation III scores as a covariate.

CONCLUSIONS:

Our retrospective analysis suggests that although patient size (i.e., body mass index) is a predictor of in-hospital death among all-comers with sepsis-providing further evidence to the obesity paradox-it adds that illness severity is critically important whether quantified as higher lactate or by Acute Physiology and Chronic Health Evaluation III score. Our results highlight that the obesity paradox is more than a simple association between body mass index and mortality and reinforces the importance of illness severity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peso Corporal / Mortalidade Hospitalar / Sepse / Obesidade Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peso Corporal / Mortalidade Hospitalar / Sepse / Obesidade Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article